Literature DB >> 23759594

A role for p38 in transcriptional elongation of p21 (CIP1) in response to Aurora B inhibition.

Geeta Kumari1, Tanja Ulrich, Stefan Gaubatz.   

Abstract

Aurora kinases play important functions in mitosis. They are overexpressed in many cancers and are targets for anticancer therapy. Inhibition of Aurora B results in cytokinesis failure and polyploidization, leading to activation of the p53 tumor suppressor and its target genes, including p21. The pathways that mediate p21 activation after Aurora B inhibition are not well understood. In this study, we identified a role for the p38 MAP kinase in activation of p21 when Aurora B is inhibited. We show that p38 is required for the acute cell cycle arrest in G 1 and to prevent endoreduplication when Aurora B is inhibited. Stabilization of p53 occurs independently of p38, and recruitment of p53 to the p21 promoter also does not require p38. Instead, enrichment of the elongating form of RNA PolII at the distal region of the p21 gene is strongly reduced when p38 is blocked, indicating that p38 acts in transcriptional elongation of p21. Thus, our results identify an unexpected role of p38 in cell cycle regulation in response to Aurora B inhibition, by promoting the transcriptional elongation of the cell cycle inhibitor p21.

Entities:  

Keywords:  Aurora B; p21; p38; p53; transcription elongation

Mesh:

Substances:

Year:  2013        PMID: 23759594      PMCID: PMC3737308          DOI: 10.4161/cc.25100

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  39 in total

1.  Tetraploid state induces p53-dependent arrest of nontransformed mammalian cells in G1.

Authors:  P R Andreassen; O D Lohez; F B Lacroix; R L Margolis
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

Review 2.  Aurora kinase inhibitors as anticancer molecules.

Authors:  Hiroshi Katayama; Subrata Sen
Journal:  Biochim Biophys Acta       Date:  2010-09-20

3.  Gene-specific requirement for P-TEFb activity and RNA polymerase II phosphorylation within the p53 transcriptional program.

Authors:  Nathan P Gomes; Glen Bjerke; Briardo Llorente; Stephanie A Szostek; Beverly M Emerson; Joaquin M Espinosa
Journal:  Genes Dev       Date:  2006-03-01       Impact factor: 11.361

4.  A role for Chk1 in blocking transcriptional elongation of p21 RNA during the S-phase checkpoint.

Authors:  Rachel Beckerman; Aaron J Donner; Melissa Mattia; Melissa J Peart; James L Manley; Joaquin M Espinosa; Carol Prives
Journal:  Genes Dev       Date:  2009-06-01       Impact factor: 11.361

5.  A biomarker that identifies senescent human cells in culture and in aging skin in vivo.

Authors:  G P Dimri; X Lee; G Basile; M Acosta; G Scott; C Roskelley; E E Medrano; M Linskens; I Rubelj; O Pereira-Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

6.  Inhibition of oncogenic transformation by mammalian Lin-9, a pRB-associated protein.

Authors:  Sladjana Gagrica; Stefanie Hauser; Ingrid Kolfschoten; Lisa Osterloh; Reuven Agami; Stefan Gaubatz
Journal:  EMBO J       Date:  2004-11-11       Impact factor: 11.598

Review 7.  Aurora kinases as anticancer drug targets.

Authors:  Oliver Gautschi; Jim Heighway; Philip C Mack; Phillip R Purnell; Primo N Lara; David R Gandara
Journal:  Clin Cancer Res       Date:  2008-03-15       Impact factor: 12.531

8.  Analysis of the distribution of the INCENPs throughout mitosis reveals the existence of a pathway of structural changes in the chromosomes during metaphase and early events in cleavage furrow formation.

Authors:  W C Earnshaw; C A Cooke
Journal:  J Cell Sci       Date:  1991-04       Impact factor: 5.285

9.  Short and long-term tumor cell responses to Aurora kinase inhibitors.

Authors:  Megan R Dreier; Aaron Z Grabovich; Jamie D Katusin; William R Taylor
Journal:  Exp Cell Res       Date:  2009-02-20       Impact factor: 3.905

10.  The chromosomal passenger complex and the spindle assembly checkpoint: kinetochore-microtubule error correction and beyond.

Authors:  Gerben Vader; André F Maia; Susanne Ma Lens
Journal:  Cell Div       Date:  2008-05-28       Impact factor: 5.130

View more
  8 in total

1.  p38 mitogen-activated protein kinase inhibits USP22 transcription in HeLa cells.

Authors:  Jianjun Xiong; Zhen Gong; Xiaou Zhou; Jianyun Liu; H E Jiang; Ping Wu; Weidong Li
Journal:  Biomed Rep       Date:  2015-04-16

2.  Induction of p21CIP1 protein and cell cycle arrest after inhibition of Aurora B kinase is attributed to aneuploidy and reactive oxygen species.

Authors:  Geeta Kumari; Tanja Ulrich; Michael Krause; Florian Finkernagel; Stefan Gaubatz
Journal:  J Biol Chem       Date:  2014-04-29       Impact factor: 5.157

3.  The p38 MAPK inhibitor BIRB796 enhances the antitumor effects of VX680 in cervical cancer.

Authors:  Xin Jin; Qingqing Mo; Yu Zhang; Yue Gao; Yuan Wu; Jing Li; Xing Hao; Ding Ma; Qinglei Gao; Pingbo Chen
Journal:  Cancer Biol Ther       Date:  2016-05-03       Impact factor: 4.742

4.  Ku70 Serine 155 mediates Aurora B inhibition and activation of the DNA damage response.

Authors:  Victoria L Fell; Elizabeth A Walden; Sarah M Hoffer; Stephanie R Rogers; Amelia S Aitken; Louisa M Salemi; Caroline Schild-Poulter
Journal:  Sci Rep       Date:  2016-11-16       Impact factor: 4.379

Review 5.  An overview of mammalian p38 mitogen-activated protein kinases, central regulators of cell stress and receptor signaling.

Authors:  Jiahuai Han; Jianfeng Wu; John Silke
Journal:  F1000Res       Date:  2020-06-29

6.  Restriction of Cellular Plasticity of Differentiated Cells Mediated by Chromatin Modifiers, Transcription Factors and Protein Kinases.

Authors:  Dylan P Rahe; Oliver Hobert
Journal:  G3 (Bethesda)       Date:  2019-07-09       Impact factor: 3.154

7.  Involvement of p38 in signal switching from autophagy to apoptosis via the PERK/eIF2α/ATF4 axis in selenite-treated NB4 cells.

Authors:  Q Jiang; F Li; K Shi; P Wu; J An; Y Yang; C Xu
Journal:  Cell Death Dis       Date:  2014-05-29       Impact factor: 8.469

8.  The negative interplay between Aurora A/B and BRCA1/2 controls cancer cell growth and tumorigenesis via distinct regulation of cell cycle progression, cytokinesis, and tetraploidy.

Authors:  Yan Wang; Ziliang Wang; Zihao Qi; Sheng Yin; Na Zhang; Yang Liu; Mingming Liu; Jiao Meng; Rongyu Zang; Zhen Zhang; Gong Yang
Journal:  Mol Cancer       Date:  2014-04-28       Impact factor: 27.401

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.